David van Duin, MD, PhD
Director, Immunocompromised Host Infectious Diseases Section
Associate Chief of Immunocompromised Host Infectious Disease Service
Professor of Medicine, Division of Infectious Diseases
Areas of Interest
Infections in immunocompromised hosts; Gram-negative bacterial resistance
About
Dr. van Duin is the founding Director of the Immunocompromised Host Infectious Diseases Program – which provides consultative Infectious Diseases care to patients with transplants, malignancies, and burns. His primary research interests are antibacterial resistance in gram-negative bacilli and infections in vulnerable immunocompromised patient populations. He leads the consortium on resistance against carbapenems in Klebsiella and other Enterobacterales (CRACKLE) and the Multi-Drug Resistant Organism (MDRO) Network of the Antibacterial Resistance Leadership Group (ARLG). He is also supported by NIAID to evaluate community origins of carbapenem-resistant Enterobacterales in the US.
Memberships
- Infectious Diseases Society of America (IDSA)
- European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
- American Society of Transplantation (AST)
- British Society for Antimicrobial Chemotherapy (BSAC)
In the news
High neighborhood deprivation is linked to both greater antimicrobial resistance and higher short‑term mortality in Enterobacterales infections. For North Carolina, the implications are clear. Tackling AMR requires not only new drugs and diagnostics but also addressing healthcare disparities that leave vulnerable populations at greater risk. Chapel Hill, NC — A new study published in CMI Communications finds … Read more Carbapenem-resistant Enterobacterales (CRE) are an important threat to the health of solid organ transplant recipients (SOTr). However, data comparing outcomes of SOTr with CRE to non-SOTr with CRE is lacking. David Van Duin, MD, PhD, performed a cohort study within 2 prospective, multicenter, cohort studies. The epidemiology, desirability of outcome rankings, outcomes, and mortality of SOTr … Read more ID Week took place October 16-19 in Los Angeles, CA, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. UNC’s Division of Infectious Diseases was well represented at the event. … Read more Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is antimicrobial resistance an important issue? … Read more
Neighborhood Deprivation Drives Higher Antimicrobial Resistance and Mortality in Enterobacterales Infections
Carbapenem-Resistant Enterobacterales in Solid Organ Transplant Recipients
ID Faculty Members, Fellows Present Studies During ID Week
Q&A: Investigators Discuss AMR Research at UNC’s Institute for Global Health and Infectious Diseases
Education
-
Medical School
University of Amsterdam
-
Residency
Jacobi Hospital
-
Fellowship
Yale University
-
PhD
Yale University